| Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
| 13/06/2025 | UBS Group AG | 11033(L) | +12,500,000(L) | 498,408,791(L) 466,826,632(S) | 13.25 12.41 | |
| 11/06/2025 | UBS Group AG | 1213(L) | -15,901,761(L) | 474,599,632(L) 464,286,417(S) | 12.62 12.34 | |
| 10/06/2025 | UBS Group AG | 1101(L) | +8,701,500(L) | HKD3.389(L) | 489,686,893(L) 472,184,151(S) | 13.02 12.55 |
| 02/06/2025 | UBS Group AG | 1306(L) | 145,788,802(L) | 478,230,055(L) 480,085,481(S) | 12.71 12.76 | |
| 30/05/2025 | UBS Group AG | 1305(L) | 12,660,880(L) | 465,355,527(L) 465,433,024(S) | 12.37 12.37 | |
| 28/05/2025 | UBS Group AG | 1305(L) | 130,638,742(L) | 468,190,302(L) 471,530,169(S) | 12.45 12.54 | |
| 27/05/2025 | UBS Group AG | 1402(S) | +24,838,597(S) | 472,535,967(L) 475,354,334(S) | 12.56 12.64 | |
| 26/05/2025 | UBS Group AG | 1502(S) | -3,781,369(S) | 463,519,141(L) 448,057,378(S) | 12.32 11.91 | |
| 23/05/2025 | UBS Group AG | 1306(L) | 129,973,185(L) | 471,276,913(L) 456,359,150(S) | 12.53 12.13 | |
| 20/05/2025 | UBS Group AG | 1306(L) | 12,781,100(L) | 462,166,213(L) 464,387,150(S) | 12.29 12.35 | |
| 19/05/2025 | UBS Group AG | 1305(L) | 148,944,620(L) | 474,250,103(L) 465,440,150(S) | 12.61 12.37 | |
| 16/05/2025 | UBS Group AG | 1305(L) | 20,836,628(L) | 463,523,580(L) 465,575,150(S) | 12.32 12.38 | |
| 15/05/2025 | UBS Group AG | 1306(L) | 158,785,020(L) | 463,494,079(L) 465,703,150(S) | 12.32 12.38 | |
| 13/05/2025 | UBS Group AG | 1305(L) | 158,123,120(L) | 484,289,585(L) 477,545,881(S) | 12.87 12.70 | |
| 12/05/2025 | UBS Group AG | 1306(L) | 150,951,776(L) | 473,142,041(L) 473,871,381(S) | 12.58 12.60 | |
| 07/05/2025 | UBS Group AG | 1305(L) | 157,800,417(L) | 469,676,353(L) 473,027,881(S) | 12.49 12.57 | |
| 05/05/2025 | UBS Group AG | 1306(L) | 157,192,708(L) | 468,837,056(L) 472,524,381(S) | 12.46 12.56 | |
| 28/04/2025 | Luye Pharma Holdings Ltd. | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
| 28/04/2025 | Shorea LBG | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
| 28/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
| 28/04/2025 | Liu Dianbo | 1314(L) | +2,000,000(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 | |
| 28/04/2025 | Luye Life Sciences Group Ltd | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
| 28/04/2025 | Nelumbo Investments Limited | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
| 28/04/2025 | Ginkgo (PTC) Limited | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
| 28/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1101(L) | +2,000,000(L) | HKD1.990(L) | 1,246,108,703(L) 212,229,950(S) | 33.13 5.64 |
| 22/04/2025 | Liu Dianbo | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | Luye Life Sciences Group Ltd | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | LuYe Pharmaceutical Investment Co., Ltd. | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | Nelumbo Investments Limited | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | Ginkgo (PTC) Limited | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | Luye Life Sciences Group Ltd | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | Luye Pharma Holdings Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | LuYe Pharmaceutical International Co., Ltd. | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | Shorea LBG | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | Shorea LBG | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | Ginkgo (PTC) Limited | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | Nelumbo Investments Limited | 1203(L) 15012(S) | -17,088,000(L) -17,088,000(S) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | Luye Pharma Holdings Ltd. | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 22/04/2025 | Liu Dianbo | 1314(L) | 17,088,000(L) | 1,244,108,703(L) 212,229,950(S) | 33.07 5.64 | |
| 1 2 3 4 5 6 7 8 9 | ||||||
| Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
| Real time quote last updated: 12/12/2025 18:00 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |